ADVANCED MICRO DEVICES INC
AMD · Nasdaq · CIK 0000002488
SIC 3674
Semiconductors & Related Devices
Category
Electronics
Entity
operating
Incorp.
DE
Fiscal Y/E
1226
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
$458.91
+3.72 (+0.82%)
Open
$460.55
High
$469.24
Low
$450.88
Prev Close
$455.19
Volume
42,132,796
52W High
$362.79
52W Low
$101.56
50-day MA
$238.20
Quote as of: 2026-05-11
Market Cap
$579.22B
P/E
137.17
P/B
8.84
PEG
1.01
EPS
2.59
BPS
38.65
Beta
2.40
ROE
6.88%
ROA
5.64%
Current Ratio
2.85
Book Value/Share
$38.65
Intrinsic Value Estimates
Multiple valuation methods, each with its own assumptions — outputs can diverge widely
Median consensus (6 methods)
$86.44B
| Method | Implied market cap | vs current |
|---|---|---|
Graham Number √(22.5 × 순이익 × 자본) | $78.39B | +639% |
Graham Formula 순이익 × (8.5 + 2 × 성장률%) | $253.60B | +128% |
Justified P/E 순이익 × 산업 평균 P/E | $65.03B | +791% |
P/B 배수 자본 × 산업 평균 P/B | $94.50B | +513% |
P/S 배수 매출 × 산업 평균 P/S | — | 매출 데이터 없음 |
DCF (Gordon) CF × (1+g) / (r − g) | $237.97B | +143% |
DDM (Gordon) D × (1+g) / (r − g) | $45.95B | +1161% |
▶ Detailed analysis — formula walk-through & scenarios
Why this conclusion
Of the 7 valuation methods, 6 were applicable. Their median fair-value lands +570.1% below the current market cap → the stock trades above most formulas' estimates (overvalued). 6 methods flag overvalued, 0 flag undervalued, the rest land within fair range. Read each formula's assumptions below before treating any single number as the answer.
Graham Number
Overvalued +638.9%√(22.5 × 순이익 × 자본)
Current
$579.22B
Implied fair
$78.39B
Gap (current − fair)
+$500.83B(+638.9%)
NetIncome = $4.33B Equity = $63.00B √(22.5 × $4.33B × $63.00B) = $78.39B
- 최대 PER 15배
- 최대 PBR 1.5배
- 안정적 흑자 기업 가정 (금융·고성장 부정확)
Graham Formula
Overvalued +128.4%순이익 × (8.5 + 2 × 성장률%)
Current
$579.22B
Implied fair
$253.60B
Gap (current − fair)
+$325.62B(+128.4%)
NetIncome = $4.33B Growth g = 164.2% → cap 25.0% Multiple = 8.5 + 2 × 25.0 = 58.5× $4.33B × 58.5 = $253.60B
- EPS 성장률 164.2%/년 가정 (직전 1년 기준)
- 무성장 기업 P/E = 8.5
- 현재 적용 배수: 58.5x
Justified P/E
Overvalued +790.8%순이익 × 산업 평균 P/E
Current
$579.22B
Implied fair
$65.03B
Gap (current − fair)
+$514.19B(+790.8%)
NetIncome = $4.33B Industry P/E = 15× $4.33B × 15 = $65.03B
- 산업 평균 PER 15x 가정 (사용자 정의 가능)
- 동종 업종 비교가 핵심 — 산업별 평균 P/E 사용 권장
P/B 배수
Overvalued +512.9%자본 × 산업 평균 P/B
Current
$579.22B
Implied fair
$94.50B
Gap (current − fair)
+$484.72B(+512.9%)
Equity = $63.00B Industry P/B = 1.5× $63.00B × 1.5 = $94.50B
- 산업 평균 PBR 1.5x 가정
- 은행·보험·자산집약적 산업에 특히 유효
P/S 배수
매출 × 산업 평균 P/S
Not applicable: 매출 데이터 없음
DCF (Gordon)
Overvalued +143.4%CF × (1+g) / (r − g)
Current
$579.22B
Implied fair
$237.97B
Gap (current − fair)
+$341.25B(+143.4%)
FCF = $6.74B Discount r = 4.0% + 5.0% = 9.0% Growth g = 6.0% $6.74B × (1 + 6.0%) / (9.0% − 6.0%) = $237.97B
- 현금흐름 입력: FCF (잉여현금흐름)
- 할인율 9.0% (무위험 4.0% + 주식위험프리미엄 5.0%)
- 영구 성장률 6.0% (실질 GDP 수준)
DDM (Gordon)
Overvalued +1160.5%D × (1+g) / (r − g)
Current
$579.22B
Implied fair
$45.95B
Gap (current − fair)
+$533.27B(+1160.5%)
- 배당 입력: 순이익의 30% (이론적 배당 — 무배당주 평가용 가정)
- 할인율 9.0%
- 배당 영구 성장률 6.0%
DCF sensitivity: discount rate × terminal growth
Each cell is the (current vs FCF × (1+g) / (r − g)) discount % under the assumed growth g and discount r.
| g \ r | 7% | 8% | 9% | 10% | 11% |
|---|---|---|---|---|---|
| 1% | +410.9% | +496.0% | +581.2% | +666.3% | +751.5% |
| 2% | +321.6% | +405.9% | +490.2% | +574.5% | +658.8% |
| 3% | +234.0% | +317.5% | +401.0% | +484.5% | +568.0% |
| 4% | +148.1% | +230.8% | +313.5% | +396.2% | +478.9% |
| 5% | +63.8% | +145.7% | +227.6% | +309.5% | +391.4% |
All estimates rest on strong assumptions. Treat the spread, not any single number, as the signal.
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-04
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of Revenue | 17,487 | 13,060 | 12,220 | 12,998 | 8,505 |
| Gross Profit | 17,152 | 12,725 | 10,460 | 10,603 | 7,929 |
| Operating Expenses | 13,458 | — | — | — | — |
| Operating Income | 3,694 | 1,900 | 401 | 1,264 | 3,648 |
| Net Income | 4,335 | 1,641 | 854 | 1,320 | 3,162 |
| EPS (Basic) | 2.67 | 1.01 | 0.53 | 0.85 | 2.61 |
| EPS (Diluted) | 2.65 | 1.00 | 0.53 | 0.84 | 2.57 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 76,926 | 69,226 | 67,885 | 67,580 | 12,419 |
| Current Assets | 26,947 | 19,049 | 16,768 | 15,019 | 8,583 |
| Cash & Equivalents | 5,539 | 3,787 | 3,933 | 4,835 | 2,535 |
| Current Liabilities | 9,455 | 7,281 | 6,689 | 6,369 | 4,240 |
| Long-term Debt | — | — | — | — | 1 |
| Total Equity | 62,999 | 57,568 | 55,892 | 54,750 | 7,497 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 7,709 | 3,041 | 1,667 | 3,565 | 3,521 |
| Investing CF | -5,533 | -1,101 | -1,423 | 1,999 | -686 |
| Financing CF | -431 | -2,062 | -1,146 | -3,264 | -1,895 |
| CapEx | 974 | 636 | 546 | 450 | 301 |
📄 SEC Filings
Quarterly Report
10-Q
2026-05-06
Open →
Current Report
8-K
2026-05-05
Open →
Proxy Statement
DEF 14A
2026-03-27
Open →
Current Report
8-K
2026-02-24
Open →
Current Report
8-K
2026-02-17
Open →
Institutional Holdings
xslForm13F_X02/primary_doc.xml
2026-02-17
Open →
Annual Report
10-K
2026-02-04
Open →
Current Report
8-K
2026-02-03
Open →
Current Report
8-K
2026-01-20
Open →
Current Report
8-K
2025-12-15
Open →
Quarterly Report
10-Q
2025-11-05
Open →
Current Report
8-K
2025-11-04
Open →
Current Report
8-K
2025-10-27
Open →
Current Report
8-K
2025-10-06
Open →
Current Report
8-K
2025-08-25
Open →
Other filings (85)
144
xsl144X01/primary_doc.xml
2026-05-08
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-28
Open →
144
xsl144X01/primary_doc.xml
2026-04-24
Open →
Insider Transaction
FORM 4
2026-04-17
Open →
144
xsl144X01/primary_doc.xml
2026-04-16
Open →
144
xsl144X01/primary_doc.xml
2026-04-15
Open →
Insider Transaction
FORM 4
2026-04-08
Open →
144
xsl144X01/primary_doc.xml
2026-04-06
Open →
ARS
ARS
2026-03-27
Open →
DEFA14A
DEFA14A
2026-03-27
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-26
Open →
Insider Transaction
FORM 4
2026-03-18
Open →
Insider Transaction
FORM 4
2026-03-16
Open →
Insider Transaction
FORM 4
2026-03-13
Open →
144
xsl144X01/primary_doc.xml
2026-03-12
Open →
144
xsl144X01/primary_doc.xml
2026-03-11
Open →
Insider Transaction
FORM 4
2026-03-06
Open →
144
xsl144X01/primary_doc.xml
2026-03-04
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-20
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
144
xsl144X01/primary_doc.xml
2026-02-17
Open →
Insider Transaction
FORM 4
2026-02-13
Open →
Insider Transaction
FORM 4
2026-02-13
Open →
144
xsl144X01/primary_doc.xml
2026-02-11
Open →
144
xsl144X01/primary_doc.xml
2026-02-11
Open →
10-K/A
10-K/A
2026-02-04
Open →
Insider Transaction
FORM 4
2026-01-21
Open →
3
FORM 3
2026-01-21
Open →
Insider Transaction
FORM 4
2026-01-20
Open →
Insider Transaction
FORM 4
2026-01-20
Open →
144
xsl144X01/primary_doc.xml
2026-01-16
Open →
3
FORM 3
2025-12-23
Open →
Insider Transaction
FORM 4
2025-12-12
Open →
144
xsl144X01/primary_doc.xml
2025-12-11
Open →
Insider Transaction
FORM 4
2025-12-08
Open →
144
xsl144X01/primary_doc.xml
2025-12-04
Open →
Insider Transaction
FORM 4
2025-12-04
Open →
Insider Transaction
FORM 4
2025-11-28
Open →
Insider Transaction
FORM 4
2025-11-26
Open →
144
xsl144X01/primary_doc.xml
2025-11-24
Open →
Insider Transaction
FORM 4
2025-11-21
Open →
144
xsl144X01/primary_doc.xml
2025-11-19
Open →
Insider Transaction
FORM 4
2025-11-18
Open →
144
xsl144X01/primary_doc.xml
2025-11-14
Open →
Insider Transaction
FORM 4
2025-10-17
Open →
144
xsl144X01/primary_doc.xml
2025-10-15
Open →
Insider Transaction
FORM 4
2025-10-08
Open →
144
xsl144X01/primary_doc.xml
2025-10-06
Open →
Insider Transaction
FORM 4
2025-09-26
Open →
144
xsl144X01/primary_doc.xml
2025-09-24
Open →
Insider Transaction
FORM 4
2025-09-17
Open →
144
xsl144X01/primary_doc.xml
2025-09-15
Open →
Insider Transaction
FORM 4
2025-09-12
Open →
144
xsl144X01/primary_doc.xml
2025-09-10
Open →
Insider Transaction
FORM 4
2025-09-04
Open →
Insider Transaction
FORM 4
2025-08-25
Open →
144
xsl144X01/primary_doc.xml
2025-08-21
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
Insider Transaction
FORM 4
2025-08-19
Open →
144
xsl144X01/primary_doc.xml
2025-08-15
Open →
Insider Transaction
FORM 4
2025-08-15
Open →
144
xsl144X01/primary_doc.xml
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →
Insider Transaction
FORM 4
2025-08-12
Open →